Evidence map›Paper›PMID 41326517›Full record

ArticleScientific reports2025

Long-read genome sequencing resolves the breakpoints of a chromosome 8;22 balanced translocation in NF2-related schwannomatosis.

Marco Montini, Lorenzo Bonacchi, Diletta Sidoti, Stefano Cuccoli, Marilena Pantaleo, Angela Peron, Irene Scuffi, Marcos F DosSantos, Romina Nassini, Francesco De Logu and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Marco Montini *Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Lorenzo Bonacchi *Department of Information Engineering, University of Florence, Florence, Italy.
Diletta Sidoti *Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Stefano CuccoliDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Marilena PantaleoDivision of Medical Genetics, Meyer Childrens' Hospital IRCCS, Firenze, Italy.
Angela PeronDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Irene ScuffiDepartment of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
Marcos F DosSantosInstituto de Ciências Biológicas (ICB), Institute of Biological Sciences, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Romina NassiniDepartment of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
Francesco De LoguDepartment of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy. francescodelogu@unifi.it.
Laura PapiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy. laura.papi@unifi.it.

Funding

Fondazione Italiana per la Ricerca sul Cancro (AIRC) ID 24503Mnesys A multiscale integrated approach to the study of the nervous system in health and disease CUP B83C22004910002National Center for Gene Therapy and Drugs based on RNA Technology CUP B13C22001010001
6 · The paper itself

Abstract

The identification of structural variant (SV) breakpoints plays a crucial role in understanding the genetic variants, mutagenic mechanisms, and functional consequences that drive various genetic diseases. While next-generation sequencing (NGS) has become a cornerstone in single nucleotide variant (SNP) discovery and characterization, short-read NGS technology faces significant challenges in resolving large genomic rearrangements such as duplications, deletions, inversions, and translocations. Nanopore sequencing offers a promising alternative by enabling precise mapping of chromosomal rearrangement breakpoints, and characterization of chromosomal alterations, thereby improving the genetic diagnosis of such conditions. Using long-read whole-genome sequencing, we examined the breakpoints of a cytogenetically balanced chromosomal translocation, t(8;22)(q13.3;q11.23), initially detected during prenatal diagnosis and later confirmed as de novo in a patient who developed NF2-associated schwannomatosis in late infancy. Nanopore sequencing revealed that the translocation disrupted the NF2 gene. This case highlights the power of nanopore long-read sequencing in detecting the exact consequences of de novo, apparently balanced translocations and in uncovering the genetic underpinnings of abnormal phenotypes. Given its ability to resolve complex SVs with high precision, nanopore sequencing might be considered a valuable complement to conventional genetic diagnostic methods, enhancing our understanding of genetic diseases and potentially improving diagnostic yield and risk assessment.

Indexed as

Chromosome BreakpointsChromosomes, Human, Pair 22NeurilemmomaNeurofibromatosesNeurofibromin 2Skin NeoplasmsTranslocation, GeneticHigh-Throughput Nucleotide SequencingHumansNanopore SequencingWhole Genome SequencingNeurofibromin 2Chromosomal translocationLong read sequencingNanopore sequencingNF2.Translocation breakpoints

Identifiers

PMID41326517
PMCPMC12775432

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.